Does Dr Reddy's Laboratories stock pay a dividend?
Dr. Reddy's Laboratories has a dividend yield of 0.43%, which is in the bottom 25% of all stocks that pay dividends. Dr. Reddy's Laboratories has only been increasing its dividend for 1 years. The dividend payout ratio of Dr. Reddy's Laboratories is 16.09%.
What is the ticker symbol for Dr Reddy's?
Dr. Reddy's Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "RDY." Who are Dr. Reddy's Laboratories' major shareholders? Dr. Reddy's Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (0.00%).
What does Dr Reddy's Laboratories do?
Sign-up to receive the latest news and ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products.
Where can I buy RDY shares?
Shares of RDY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is Dr. Reddys share price and what are the returns for Dr. Reddys share?
As on 10 Jun, 2022, 03:58 PM IST Dr. Reddys share price was up by 0.66% basis the previous closing price of Rs 4,143.95. Dr. Reddys share price was...
Who are the peers for Dr. Reddys in Pharmaceuticals sector?
Top 10 Peers for Dr. Reddys are Cipla Ltd., Torrent Pharmaceuticals Ltd., Gland Pharma Ltd., Divi's Laboratories Ltd., Biocon Ltd., Alkem Laborator...
Who owns Dr. Reddys?
Promoter holding have gone down from 26.73 (30 Jun 2021) to 26.72 (31 Mar 2022) Domestic Institutional Investors holding has gone up from 15.73 (30...
What has been highest price of Dr. Reddys share in last 52 weeks?
Dr. Reddys share price saw a 52 week high of Rs 5,614.60 and 52 week low of Rs 3,654.00.
What are the key metrics to analyse Dr. Reddys Share Price?
Key Metrics for Dr. Reddys are: PE Ratio of Dr. Reddys is 33.18 Earning per share of Dr. Reddys is 131.14 Price/Sales ratio of Dr. Reddys is 3.33 P...
What is the market cap of Dr. Reddys?
Market Capitalization of Dr. Reddys stock is Rs 72,421.04 Cr.
Should I buy or sell Dr. Reddy's Laboratories stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dr. Reddy's Laboratories in the last twelve months. There are cur...
What is Dr. Reddy's Laboratories' stock price forecast for 2022?
2 brokers have issued twelve-month price objectives for Dr. Reddy's Laboratories' shares. Their RDY stock forecasts range from $63.41 to $70.00. On...
How has Dr. Reddy's Laboratories' stock performed in 2022?
Dr. Reddy's Laboratories' stock was trading at $65.41 at the beginning of 2022. Since then, RDY shares have decreased by 15.7% and is now trading a...
Are investors shorting Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,860,000 shar...
When is Dr. Reddy's Laboratories' next earnings date?
Dr. Reddy's Laboratories is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022. View our earnings forecast f...
How were Dr. Reddy's Laboratories' earnings last quarter?
Dr. Reddy's Laboratories Limited (NYSE:RDY) announced its earnings results on Friday, October, 29th. The company reported $0.80 EPS for the quarter...
How often does Dr. Reddy's Laboratories pay dividends? What is the dividend yield for Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories announced an annual dividend on Wednesday, June 16th. Shareholders of record on Friday, July 9th will be given a dividend...
Is Dr. Reddy's Laboratories a good dividend stock?
Dr. Reddy's Laboratories(NYSE:RDY) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.51%. The dividend payout rati...
Who are Dr. Reddy's Laboratories' key executives?
Dr. Reddy's Laboratories' management team includes the following people: Mr. Gunupati Venkateswara Prasad B.E. , Co-Chairman, MD & Member of Mana...
About Dr. Reddy's Laboratories
Dr. Reddy's Laboratories (NYSE:RDY) Frequently Asked Questions
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others.
NYSE
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dr. Reddy's Laboratories in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Dr. Reddy's Laboratories stock. View analyst ratings for Dr.
Environmental, Social, and Governance Rating
A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
What is Dr Reddy's Laboratories' stock symbol?
A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.
How do I buy shares of Dr Reddy's Laboratories?
Dr Reddy's Laboratories trades on the OTCMKTS under the ticker symbol "DRREDDY."
